000			01724 a2200469 4500
005			20250513223221.0
264		0	_c20001109
008			200011s 0 0 eng d
022			_a0024-3205
024	7		_a10.1016/s0024-3205(00)00800-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aJinsmaa, Y
245	0	0	_aAnti-analgesic and anti-amnesic effect of complement C3a. _h[electronic resource]
260			_bLife sciences _cSep 2000
300			_a2137-43 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer _xadministration & dosage
650	0	4	_aAnalgesics _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aAvoidance Learning _xdrug effects
650	0	4	_aCerebral Ventricles _xdrug effects
650	0	4	_aComplement C3a _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aElectroshock
650	0	4	_aHumans
650	0	4	_aInjections, Intraventricular
650	0	4	_aIschemia _xphysiopathology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred Strains
650	0	4	_aMorphine _xadministration & dosage
650	0	4	_aOligopeptides _xadministration & dosage
650	0	4	_aPain _xphysiopathology
650	0	4	_aReceptors, Opioid, delta _xagonists
650	0	4	_aReceptors, Opioid, kappa _xagonists
650	0	4	_aReceptors, Opioid, mu _xagonists
700	1		_aTakahashi, M
700	1		_aTakahashi, M
700	1		_aYoshikawa, M
773	0		_tLife sciences _gvol. 67 _gno. 17 _gp. 2137-43
856	4	0	_uhttps://doi.org/10.1016/s0024-3205(00)00800-6 _zAvailable from publisher's website
999			_c11000482 _d11000482